Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-19-003738

Chief Medical Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Berger Mark Stanley · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-03-05 Option exercise : show line 1 in the form +3,500 $0.60 $2,100 22,500 D
Loading xslF345X03/ownership.xml…